| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.700 | None | 0.982 | 13 | 0 | 1995 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 0.979 | 8 | 0 | 1996 | 2020 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
disease | 0.700 | None | 0.953 | 6 | 0 | 1995 | 2019 | ||||||||
|
interleukin 5 | 0.437 | 0.846 | 5.7E-03 |
|
disease | 0.700 | None | 0.973 | 4 | 0 | 1991 | 2020 | ||||||||
|
T-box transcription factor 21 | 0.541 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.944 | 4 | 0 | 2002 | 2019 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.600 | None | 0.964 | 10 | 0 | 1992 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.600 | None | 0.861 | 4 | 0 | 2001 | 2019 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.600 | None | 0.886 | 4 | 0 | 1996 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.600 | None | 1.000 | 4 | 0 | 1995 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.600 | None | 0.900 | 2 | 0 | 1997 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.600 | None | 0.955 | 1 | 0 | 1992 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.500 | None | 0.978 | 14 | 0 | 1990 | 2019 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.500 | None | 0.956 | 10 | 0 | 1993 | 2020 | ||||||||
|
ORMDL sphingolipid biosynthesis regulator 3 | 0.666 | 0.423 | 0.78 |
|
disease | 0.500 | None | 0.986 | 5 | 0 | 2007 | 2019 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.500 | None | 0.950 | 4 | 0 | 1997 | 2020 | ||||||||
|
secretoglobin family 3A member 2 | 0.686 | 0.462 | 6.1E-03 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 2001 | 2017 | ||||||||
|
thymic stromal lymphopoietin | 0.486 | 0.808 | 4.0E-03 |
|
disease | 0.500 | None | 0.989 | 3 | 0 | 2005 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.500 | None | 0.933 | 1 | 0 | 1996 | 2019 | ||||||||
|
interleukin 1 receptor like 1 | 0.547 | 0.731 | 1.4E-12 |
|
disease | 0.500 | None | 0.951 | 1 | 0 | 2008 | 2020 | ||||||||
|
major histocompatibility complex, class I, G | 0.461 | 0.769 | 1.4E-11 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.875 | 1 | 0 | 1997 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.490 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
neuropeptide S receptor 1 | 0.608 | 0.615 | 2.1E-09 |
|
disease | 0.400 | None | 0.947 | 11 | 0 | 2004 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.896 | 8 | 0 | 2000 | 2019 | ||||||||
|
interleukin 4 receptor | 0.474 | 0.846 | 2.3E-04 |
|
disease | 0.400 | None | 0.954 | 7 | 0 | 1999 | 2020 |